New York, New York - April 08, 2026 - PRESSADVANTAGE - Silverback AI Chatbot has released an announcement outlining the ...
New York, New York - April 01, 2026 - PRESSADVANTAGE - Silverback AI Chatbot has released an announcement providing a ...
In a hypothetical clash of titans, a king cobra and a silverback gorilla face off. The cobra relies on potent venom and agility, while the gorilla boasts immense strength and intelligence. Despite the ...
The case alleges that the Offering Documents and Silverback and its senior executives made misleading statements to investors and failed to disclose that: (i) Silverback's lead product candidate ...
LOVE IT SO MUCH. ALL RIGHT JEFF THANK YOU. WE DO HAVE TO BRING YOU SOME BREAKING NEWS RIGHT NOW. THE PITTSBURGH ZOO AND AQUARIUM IS ANNOUNCING THE DEATH OF MURTHY, THE ZOO’S SILVERBACK WESTERN GORILLA ...
Silverback Therapeutics will lay off 27% of its workforce and close its oncology program, the Seattle company announced Thursday in its fourth quarter earnings report. The company reported ...
- Strategic realignment to focus resources on SBT8230 for chronic hepatitis B virus (cHBV) and discovery pipeline by discontinuing SBT6050 and SBT6290 clinical oncology programs - On track to complete ...
As Silverback admits defeat, ARS troops forward to fund commercialization of epinephrine nasal spray
ARS Pharmaceuticals is backing onto Nasdaq through a reverse merger with Silverback Therapeutics to bag cash to commercialize an epinephrine nasal spray and win market share from the incumbent EpiPen.
SBT6290 Shown to Activate Myeloid Cells and Drive Anti-tumor Effects in Nectin4-expressing Solid Tumors “SBT6290 showcases the versatility of our ImmunoTAC platform and along with our lead program ...
New York, New York - March 25, 2026 - PRESSADVANTAGE - Silverback AI Chatbot has released an announcement detailing its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results